| Deborah Karen Stephenson, MD;MPH | |
|
2425 Enborg Ln, Puentes Clinic, San Jose, CA 95128-2648 | |
| (408) 885-5400 | |
| Not Available |
| Full Name | Deborah Karen Stephenson |
|---|---|
| Gender | Female |
| Speciality | Preventive Medicine - Public Health & General Preventive Medicine |
| Location | 2425 Enborg Ln, San Jose, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689767121 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083P0901X | Preventive Medicine - Public Health & General Preventive Medicine | G68215 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Deborah Karen Stephenson, MD;MPH 751 S Bascom Ave, San Jose, CA 95128-2604 Ph: () - | Deborah Karen Stephenson, MD;MPH 2425 Enborg Ln, Puentes Clinic, San Jose, CA 95128-2648 Ph: (408) 885-5400 |
News Archive
Genzyme, a Sanofi Company, announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's supplemental Biologics License Application (sBLA) file seeking approval of LEMTRADA (alemtuzumab) for the treatment of relapsing multiple sclerosis (RMS).
The cause of lung cancer in never-smokers is poorly understood, but a study led by investigators at the Ohio State University Comprehensive Cancer Center and at the National Cancer Institute has identified a molecule believed to play an early and important role in its development.
A new study shows that neither of two commonly used radiation treatments for early-stage, node-negative breast cancer has any effect on a woman's immune system, even though women who receive five-day partial-breast radiation therapy (MammoSite brachytherapy) (PBRT) have improved energy and quality of life compared to women who undergo six weeks of whole-breast radiation therapy (WBRT).
In one of only two studies of its kind, a study from researchers at Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts demonstrates that non-viral gene therapy can delay the onset of some forms of eye disease and preserve vision. The team developed nanoparticles to deliver therapeutic genes to the retina and found that treated mice temporarily retained more eyesight than controls.
› Verified 6 days ago
Sonya L J Meyers, MD Preventive Medicine Medicare: Medicare Enrolled Practice Location: 275 Hospital Pkwy, 5th Floor, San Jose, CA 95119 Phone: 669-245-0161 | |
Elizabeth D. E. Kaiser, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 260 International Cir, San Jose, CA 95119 Phone: 408-972-7000 | |
Dr. Masaaki Tsuruike, PHD, ATC Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: One Washington Square, San Jose, CA 95192 Phone: 408-924-3040 | |
Dr. Margarita Elsa Villarino, MD MPH Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 976 Lenzen Ave Ste 1700, San Jose, CA 95126 Phone: 669-287-8095 | |
Lavanya Kailar, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 260 International Cir, San Jose, CA 95119 Phone: 408-972-7000 | |
Devina D. Grover, MD Preventive Medicine Medicare: Medicare Enrolled Practice Location: 260 International Cir, San Jose, CA 95119 Phone: 408-972-7000 | |
Thao N. Pham, DO Preventive Medicine Medicare: Medicare Enrolled Practice Location: 260 International Cir, San Jose, CA 95119 Phone: 408-972-7000 |